世界の関節リウマチ（RA）治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Rheumatoid Arthritis (RA) Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z11993 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、関節リウマチ（RA）治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。関節リウマチ（RA）治療薬の種類別市場規模（NSAID、鎮痛薬、コルチコステロイド、DMARD、生物学的療法、JAK阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・関節リウマチ（RA）治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Roche、Merck、HEYL Chemisch-pharmazeutische Fabrik、Johnson & Johnson、Amgen, Inc.、Pfizer、Bristol-Myers Squibb、UCB、GSK、Sanofi、Abbott Laboratories、Teva Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：NSAID、鎮痛薬、コルチコステロイド、DMARD、生物学的療法、JAK阻害剤 ・用途別分析2016年-2026年：病院、診療所、その他 ・関節リウマチ（RA）治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・関節リウマチ（RA）治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・関節リウマチ（RA）治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・関節リウマチ（RA）治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・関節リウマチ（RA）治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Rheumatoid Arthritis (RA) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Rheumatoid Arthritis (RA) Drugs size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Rheumatoid Arthritis (RA) Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Rheumatoid Arthritis (RA) Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
NSAIDs
Analgesic Drugs
Corticosteroids
DMARDs
Biological Therapies
JAK-inhibitors

Market segment by Application, can be divided into
Hospitals
Clinics
Others

Market segment by players, this report covers
AbbVie
Roche
Merck
HEYL Chemisch-pharmazeutische Fabrik
Johnson & Johnson
Amgen, Inc.
Pfizer
Bristol-Myers Squibb
UCB
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis (RA) Drugs
1.2 Classification of Rheumatoid Arthritis (RA) Drugs by Type
1.2.1 Overview: Global Rheumatoid Arthritis (RA) Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type in 2020
1.2.3 NSAIDs
1.2.4 Analgesic Drugs
1.2.5 Corticosteroids
1.2.6 DMARDs
1.2.7 Biological Therapies
1.2.8 JAK-inhibitors
1.3 Global Rheumatoid Arthritis (RA) Drugs Market by Application
1.3.1 Overview: Global Rheumatoid Arthritis (RA) Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Rheumatoid Arthritis (RA) Drugs Market Size & Forecast
1.5 Global Rheumatoid Arthritis (RA) Drugs Market Size and Forecast by Region
1.5.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Region, (2016-2021)
1.5.3 North America Rheumatoid Arthritis (RA) Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Rheumatoid Arthritis (RA) Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rheumatoid Arthritis (RA) Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rheumatoid Arthritis (RA) Drugs Market Drivers
1.6.2 Rheumatoid Arthritis (RA) Drugs Market Restraints
1.6.3 Rheumatoid Arthritis (RA) Drugs Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.1.4 AbbVie Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.2.4 Roche Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.3.4 Merck Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 HEYL Chemisch-pharmazeutische Fabrik
2.4.1 HEYL Chemisch-pharmazeutische Fabrik Details
2.4.2 HEYL Chemisch-pharmazeutische Fabrik Major Business
2.4.3 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.4.4 HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 HEYL Chemisch-pharmazeutische Fabrik Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.5.4 Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Amgen, Inc.
2.6.1 Amgen, Inc. Details
2.6.2 Amgen, Inc. Major Business
2.6.3 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.6.4 Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen, Inc. Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.7.4 Pfizer Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.8.4 Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 UCB
2.9.1 UCB Details
2.9.2 UCB Major Business
2.9.3 UCB Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.9.4 UCB Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 UCB Recent Developments and Future Plans
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.10.4 GSK Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 GSK Recent Developments and Future Plans
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.11.4 Sanofi Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sanofi Recent Developments and Future Plans
2.12 Abbott Laboratories
2.12.1 Abbott Laboratories Details
2.12.2 Abbott Laboratories Major Business
2.12.3 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.12.4 Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Abbott Laboratories Recent Developments and Future Plans
2.13 Teva Pharmaceutical
2.13.1 Teva Pharmaceutical Details
2.13.2 Teva Pharmaceutical Major Business
2.13.3 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product and Solutions
2.13.4 Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Teva Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatoid Arthritis (RA) Drugs Players Market Share
3.2.2 Top 10 Rheumatoid Arthritis (RA) Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Rheumatoid Arthritis (RA) Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rheumatoid Arthritis (RA) Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Rheumatoid Arthritis (RA) Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application (2016-2021)
5.2 Rheumatoid Arthritis (RA) Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2026)
6.2 North America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2026)
6.3 North America Rheumatoid Arthritis (RA) Drugs Market Size by Country
6.3.1 North America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2026)
6.3.2 United States Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2026)
7.2 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2026)
7.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Country
7.3.1 Europe Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2026)
7.3.2 Germany Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
7.3.3 France Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Market Size by Region
8.3.1 Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Region (2016-2026)
8.3.2 China Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8.3.5 India Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2026)
9.2 South America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2026)
9.3 South America Rheumatoid Arthritis (RA) Drugs Market Size by Country
9.3.1 South America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Market Size by Country
10.3.1 Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Rheumatoid Arthritis (RA) Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Rheumatoid Arthritis (RA) Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rheumatoid Arthritis (RA) Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rheumatoid Arthritis (RA) Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Region (2021-2026)
Table 6. AbbVie Corporate Information, Head Office, and Major Competitors
Table 7. AbbVie Major Business
Table 8. AbbVie Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 9. AbbVie Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche Corporate Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 13. Roche Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 17. Merck Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. HEYL Chemisch-pharmazeutische Fabrik Corporate Information, Head Office, and Major Competitors
Table 19. HEYL Chemisch-pharmazeutische Fabrik Major Business
Table 20. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 21. HEYL Chemisch-pharmazeutische Fabrik Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 25. Johnson & Johnson Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Amgen, Inc. Major Business
Table 28. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 29. Amgen, Inc. Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 33. Pfizer Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 35. Bristol-Myers Squibb Major Business
Table 36. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 37. Bristol-Myers Squibb Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. UCB Corporate Information, Head Office, and Major Competitors
Table 39. UCB Major Business
Table 40. UCB Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 41. UCB Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. GSK Corporate Information, Head Office, and Major Competitors
Table 43. GSK Major Business
Table 44. GSK Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 45. GSK Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sanofi Corporate Information, Head Office, and Major Competitors
Table 47. Sanofi Major Business
Table 48. Sanofi Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 49. Sanofi Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 51. Abbott Laboratories Major Business
Table 52. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 53. Abbott Laboratories Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 55. Teva Pharmaceutical Major Business
Table 56. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Product and Solutions
Table 57. Teva Pharmaceutical Rheumatoid Arthritis (RA) Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) by Players (2019-2021)
Table 59. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players (2019-2021)
Table 60. Breakdown of Rheumatoid Arthritis (RA) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Rheumatoid Arthritis (RA) Drugs Players Head Office, Products and Services Provided
Table 62. Rheumatoid Arthritis (RA) Drugs Mergers & Acquisitions in the Past Five Years
Table 63. Rheumatoid Arthritis (RA) Drugs New Entrants and Expansion Plans
Table 64. Global Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) by Type (2016-2021)
Table 65. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type (2016-2021)
Table 66. Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Type (2021-2026)
Table 67. Global Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021)
Table 68. Global Rheumatoid Arthritis (RA) Drugs Revenue Forecast by Application (2021-2026)
Table 69. North America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Rheumatoid Arthritis (RA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Rheumatoid Arthritis (RA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Rheumatoid Arthritis (RA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Rheumatoid Arthritis (RA) Drugs Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Rheumatoid Arthritis (RA) Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rheumatoid Arthritis (RA) Drugs Picture
Figure 2. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Type in 2020
Figure 3. NSAIDs
Figure 4. Analgesic Drugs
Figure 5. Corticosteroids
Figure 6. DMARDs
Figure 7. Biological Therapies
Figure 8. JAK-inhibitors
Figure 9. Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Application in 2020
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Rheumatoid Arthritis (RA) Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Rheumatoid Arthritis (RA) Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Region (2016-2026)
Figure 16. Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Region in 2020
Figure 17. North America Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Rheumatoid Arthritis (RA) Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Rheumatoid Arthritis (RA) Drugs Market Drivers
Figure 22. Rheumatoid Arthritis (RA) Drugs Market Restraints
Figure 23. Rheumatoid Arthritis (RA) Drugs Market Trends
Figure 24. AbbVie Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. HEYL Chemisch-pharmazeutische Fabrik Recent Developments and Future Plans
Figure 28. Johnson & Johnson Recent Developments and Future Plans
Figure 29. Amgen, Inc. Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 32. UCB Recent Developments and Future Plans
Figure 33. GSK Recent Developments and Future Plans
Figure 34. Sanofi Recent Developments and Future Plans
Figure 35. Abbott Laboratories Recent Developments and Future Plans
Figure 36. Teva Pharmaceutical Recent Developments and Future Plans
Figure 38. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Players in 2020
Figure 39. Rheumatoid Arthritis (RA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2020
Figure 41. Global Top 10 Players Rheumatoid Arthritis (RA) Drugs Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Type in 2020
Figure 44. Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Type (2021-2026)
Figure 45. Global Rheumatoid Arthritis (RA) Drugs Revenue Share by Application in 2020
Figure 46. Global Rheumatoid Arthritis (RA) Drugs Market Share Forecast by Application (2021-2026)
Figure 47. North America Rheumatoid Arthritis (RA) Drugs Sales Market Share by Type (2016-2026)
Figure 48. North America Rheumatoid Arthritis (RA) Drugs Sales Market Share by Application (2016-2026)
Figure 49. North America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Country (2016-2026)
Figure 50. United States Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Rheumatoid Arthritis (RA) Drugs Sales Market Share by Type (2016-2026)
Figure 54. Europe Rheumatoid Arthritis (RA) Drugs Sales Market Share by Application (2016-2026)
Figure 55. Europe Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Country (2016-2026)
Figure 56. Germany Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Region (2016-2026)
Figure 64. China Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Rheumatoid Arthritis (RA) Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Rheumatoid Arthritis (RA) Drugs Sales Market Share by Application (2016-2026)
Figure 72. South America Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Rheumatoid Arthritis (RA) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source

---